India Q2 FY27 Earnings Roundup: Tata Motors Revenue +42%, Jindal Steel Records, CSB Bank NIM Holds

The Quick Take

• Tata Motors Q2 FY27 revenue jumped 42% YoY with record wholesale volumes and free cash flow generation, though commodity costs and supply chain constraints are emerging margin risks
• Jindal Steel achieved record quarterly revenue of INR16,704 crore and 2.38 million tonnes sales volume, flagging rising coking coal costs and project delays as near-term pressures
• CSB Bank posted 22% sequential profit growth to INR183 crore with NIM at 3.81% and GNPA at 1.58%, guiding return on assets at 1.5-1.8%
• Torrent Pharmaceuticals maintained 33.5% EBITDA margin in Q2 but flagged JB integration disruptions in Germany and international markets; Rallis India EBITDA fell 18% on erratic monsoon

India's Q2 FY27 earnings season produced a divergent set of outcomes across mid-to-large cap sectors, with Tata Motors and Jindal Steel recording strong topline growth contrasting with operational headwinds at Torrent Pharmaceuticals and Rallis India. Tata Motors reported a 42% year-on-year revenue jump in Q2 FY27 with record wholesale volumes and free cash flow generation, driven by robust electric vehicle and commercial vehicle demand across domestic and export markets. Jindal Steel achieved a record quarterly revenue of INR16,704 crore with 2.38 million tonnes of steel sales volume, though management flagged rising coking coal input costs and project commissioning delays as near-term margin pressures in Q3.

CSB Bank provided a bright spot within the financial services segment, reporting 22% sequential net profit growth to INR183 crore with net interest margin held at 3.81% and gross non-performing assets at 1.58%, with management guiding for return on assets of 1.5-1.8% over the next year. Torrent Pharmaceuticals maintained a 33.5% EBITDA margin in Q2 but acknowledged integration disruptions from the JB Chemicals acquisition across German and select international distribution channels, which tempered the near-term outlook. Rallis India, the Tata Group agri-inputs subsidiary, saw EBITDA decline 18% on erratic monsoon rainfall that compressed domestic crop protection volumes, partially offset by a 12-fold rebound in CSM contract manufacturing revenue.

The primary forward indicators from this earnings batch are Tata Motors Q3 commodity cost trajectory in steel and aluminum, which will determine whether the 42% topline growth translates to margin expansion, and Jindal Steel's capacity utilization at new facilities alongside coking coal procurement dynamics. For Torrent Pharmaceuticals, the pace of JB integration normalization across European channels will be the margin recovery catalyst. Rallis India's Rabi crop protection volumes, determined by northeast monsoon progression, provide the Q3 guidance signal. The macro variable governing these diverse mid-cap names collectively is domestic consumption demand and the trajectory of input costs in steel, pharmaceutical actives, and agri-chemicals.

Synthesized from 6 sources.